Tenders Are Invited For Completion Of A Non-Excl. Discount Agreement According To § 130A Paragraph 8 Sgb V F ...

Work Detail

Completion Of A Non-Excl. Discount Agreement According To § 130A Paragraph 8 Sgb V For Leflunomide, Atc Code: L04aa13 For The Period From October 1St, 2023 To September 30Th, 2025. The Present Announcement Serves To Conclude Drug Discount Contracts In Accordance With § 130A Paragraph 8 Sgb V For The Active Substance(S) Mentioned Under Point Ii.1.1). It Is Not About The Award Of Public Contracts Within The Meaning Of Directive 2014/24/Eu Or Sections 97 Ff Gwb. Any Pharmaceutical Company Can Become A Contractual Partner In Accordance With Section 4 (18) Amg. According To The Case Law Of The Ecj, Such Approval Procedures Are Not Necessarily Subject To Public Procurement Law, Since There Is No Competition Due To The Lack Of A Selection Decision. The Announcement Serves As An Invitation To Conclude Discount Agreements With The Same Non-Dispositive Conditions That Apply To All Contractual Partners, Including The Determination Of The Discount. The Contract Is Concluded By Signing The Contract Documents And Submitting The Required Declarations, Which Can Be Requested From The Contact Point Named Under I.3).

Contact Information

Other Detail